4 Einträge gefunden

1. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

   1. Wolschke, Christine
   2. Stübig, Thomas
   3. Hegenbart, Ute
   4. Schönland, Stefan
   5. Heinzelmann, Marion
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2013 - Forschungsinformationssystem des UKE
2. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
3. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
4. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE